We found that the densities of the PAMAs clustering were considerably increased from AD mice between the treatments with vehicle and ALA and EDA, with over 50% increase in the number of GPR120-positive PAMAs in both cortex and hippocampus (Fig. 5e,f). The gene discussed is FFAR4; the disease is Alzheimer disease.